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“In situ” Functionalized Polymers for siRNA Delivery ** 
Juan M. Priegue,a Daniel N. Crisan,c José Martínez-Costas,b Juan R. Granja,a Francisco Fernandez-
Trillo,* ,c and Javier Montenegro.*, a 
Abstract: Here we report a new methodology to screen for the 
biological activity of functional polymers across a consistent degree 
of polymerization and in situ, i.e. in aqueous conditions and without 
purification/isolation of candidate polymers. In brief, the chemical 
functionality of a poly(acryloyl hydrazide) scaffold was activated 
under aqueous conditions using readily available aldehydes to 
obtain amphiphilic polymers. The transport activity of the resulting 
polymers can be in situ evaluated using model membranes and 
living cells without the need of tedious isolation and purification. 
This technology allowed the rapid identification of a 
supramolecular polymeric vector with excellent efficiency and 
reproducibility for the delivery of siRNA into human cells (HeLa-
EGFP). The reported methodology constitutes a blueprint for the 
high-throughput screening and future discovery of new polymeric 
functional materials with relevant biological applications. 
Polymers are emerging as one of the most promising 
scaffolds for the multivalent presentation of relevant biological 
information.[1,2] The polymeric display of chemical motifs triggers 
new opportunities for cargo conjugation and delivery of the 
resulting covalent and/or supramolecular nanocomposites.[3] 
Polymers have been suggested as one of the best nanomaterials for 
drug delivery.[3,4] Along these lines, the delivery of exogenous small 
interfering RNA (siRNA),[5,6] is one of the potential therapies where 
polymers have attracted great attention.[7] RNAi can regulate gene 
expression in a catalytic manner, and as such, offers several 
advantages over other gene therapies.[8] However, the potential 
biosafety problems associated with viral vectors and the intrinsic 
limitations of siRNA (e.g. nuclease digestion) strongly hinder the 
development of suitable therapies.[6] It is therefore crucial to 
innovate and to identify new synthetic vectors for the delivery of 
functional polynucleotides. 
Current progress in polymer synthesis allows the preparation 
of materials with multiple functionalities capable of mimicking 
some of the desired characteristics of viral vectors for gene 
delivery.[7,9] To speed up this discovery process, screening strategies 
have been developed.[10-14] However, in most of these cases the 
monomer composition strongly affects the outcome of the 
polymerization results.[15] Furthermore, these platforms are often 
compromised by the lack of strategies that allow evaluation of a 
range of chemical compositions across a consistent molecular 
weight and/or polymer length. Moreover, there are even less 
protocols that allow the in situ evaluation of the generated 
polynucleotide vectors.[12] Therefore, purification/isolation steps 
have to be implemented, even for inactive candidates, increasing 
this way the time and cost of the discovery process. Unfortunately, 
as the sophistication in polymer design increases, so does the 
synthetic effort required to prepare polymer vectors. 
In this paper we report the synthesis of poly(acryloyl 
hydrazide)s for their straightforward functionalization with 
aldehydes to afford amphiphilic polymers that can be in situ (i.e. in 
aqueous conditions and without further purification) screened for the 
activated transport of nucleotides across lipid membranes (Scheme 
I). Optimization of these hydrazone-activated polymers can be 
performed in aqueous conditions and without purification, 
minimizing the synthetic effort and the time required to identify 
novel candidates for polynucleotide delivery. This versatile 
technology allowed the rapid identification of a single component 
formulation for the delivery of siRNA with better performance than 
one of the best commercial reagents (lipofectamine RNAiMAX®). 
Post-polymerization functionalization is an ideal strategy to 
develop and to evaluate polymer compositions across a consistent 
degree of polymerization.[16] Post-polymerization often relies on 
highly efficient reactions (e.g. cycloadditions, reversible carbonyl 
chemistry, thiol-ene) to modify polymer properties.[16] Of these, we 
anticipated that using a poly(acryloyl hydrazide) scaffold (P1, 
Scheme 1) would give the required solubility in water to be able to 
screen for siRNA delivery without the need to purify the candidate 
amphiphiles. Poly(hydrazides) are weakly protonated at neutral 
pH[10] and  can readily react with aldehydes to form acyl hydrazones 
that are sufficiently stable under physiological conditions.[17] 
Accordingly, hydrazone formation has been widely used in 
biological settings including drug delivery,[18] sensing,[19,20] or even 
in the synthesis of polynucleotides delivery vectors.[21,22] However, 
the use of poly(hydrazide) as a “clickable” and versatile scaffold has 
been limited and only a set of examples report its use to synthesize 
glycopolymers or for pH responsive drug delivery.[16,23,24] 
Alternative elegant strategies for multi-hydrazone formation have 
also been developed in the context of DNA or protein templated 
dynamic combinatorial libraries. [25-28] 
Post-polymerization for siRNA 
delivery 
DOI: 10.1002/anie.201((will be filled in by the editorial staff)) 
[a] Mr. J. M. Priegue, Prof. Dr. J. R. Granja and Dr. J. Montenegro.* 
Departamento de Química Orgánica. 
Centro Singular de Investigación en Química Biolóxica e Materiais 
Moleculares   (CIQUS). 
Universidade de Santiago de Compostela E-15782 Spain 
E-mail: javier.montenegro@usc.es 
[b] Dr. J. Martínez-Costas 
Departamento de Bioquimica y Biología Molecular. 
Centro Singular de Investigación en Química Biolóxica e Materiais 
Moleculares   (CIQUS). 
Universidade de Santiago de Compostela E-15782 Spain 
[c] Mr. D. N. Crisan and Dr. F. Fernandez-Trillo* 
School of Chemistry 
University of Birmingham 
B15 2TT, UK 
** Supporting information for this article is given via a link at the end of 
the document.((Please delete this text if not appropriate)) 
 
2 
 
Scheme 1. Post-polymerization functionalization with cationic and hydrophobic aldehydes is followed by supramolecular conjugation of activated polymers with 
cargo (siRNA) and polyplex delivery. 
The proposed poly(acryloyl hydrazide) scaffold (P1) was 
prepared using controlled free radical polymerization (Supporting 
Information, SI). P1 was highly water-soluble and aqueous 
hydrazone formation was readily confirmed by employing the UV-
active 4-imidazolecarboxaldehyde. 1H NMR analysis of P1 
incubated (< 1 h) with 4-imidazolecarboxaldehyde (0.3-0.9 eq in 
100 mM AcOH in D2O) showed a broadening of the aromatic peaks 
of the aldehyde (Figure S3). Comparison of the residual aldehyde 
peak against the overall amount of protons revealed that the loading 
of 4-imidazolecarboxaldehyde on P1 was ∼70% (Figure S3).[23] No 
increase in loading was observed with higher equivalents of 
aldehyde (Im), longer times (up to 4h), different solvents or even 
heating. Further characterization was obtained from GPC (Figure 1). 
A clear polymer signal [P1(Imidazol), Rt 18 min] was already 
detected with only 0.25 eq 4-imidazolecarboxaldehyde added to P1, 
confirming chromophor attachment to P1 (Figure 1). Increasing 
amounts of 4-imidazolecarboxaldehyde resulted in an increase in the 
intensity of the peak at 18 min, with that signal reaching a maximum 
at around 0.75 eq. Further equivalents simply increased the amount 
of free 4-imidazolecarboxaldehyde (Rt 31 min), validating the NMR 
estimation of a maximum polymer loading of ∼70% (Figure S3). 
Having established the feasibility of modifying P1 
functionality with a model aldehyde, we explored the use of P1 for 
the in situ screening of membrane active polymers. A close 
inspection of some of the structural motifs commonly found in 
membrane active polymers (e.g. antimicrobial or cell-penetrating 
polymers) highlights a high prevalence of amphiphilic structures 
with the presence of both cationic (e.g. guanidinium) and 
hydrophobic moieties (e.g. isopropyl, benzyl).[19,29,30] The potential 
of establishing bidentate hydrogen bonding and the stable 
protonation under physiological conditions, makes the guanidium 
group (pKa ∼ 12.5) the optimal cationic moiety for membrane 
penetration. Thus, we decided to investigate a small library of 
aldehydes where the cationic aldehyde (1, Scheme 1) was 
maintained constant and independently combined with different 
hydrophobic aldehydes (Figure 2 and SI). 
Activated polymers for membrane transport were thus 
prepared by combining an aqueous stock solution of P1 with a 
DMSO solution containing the cationic and the corresponding 
hydrophobic aldehydes in different molar ratios (SI for details). 
Hydrazone formation of P1 with long hydrophobic aldehydes (≥ 8 
carbon atoms) lead to the rapid precipitation of the resulting 
polymers, making these combinations inappropriate for further 
evaluation. However, combination of a series of short hydrophobic 
aldehydes (e.g. isovaleraldehyde (2)) with 1 afforded water soluble 
and stable hydrazone polyhydrazones nanoparticles (Figure S4). 
DLS analysis revealed suitable sizes for membrane transport (∼ 200 
nm) at a molar ratio of cationic/hydrophobic aldehydes = 0.85:0.15 
(Figures S4 and S17).[21] Neighbouring effects (i.e. cation repulsion) 
could impact the final composition of the final hydrazone-modified 
polymer. Therefore, to further characterize the post-polymerization 
reaction, we measured DLS and zeta potential of P1 combined with 
different ratios of guanidinium aldehyde (1) and isovaleraldehyde 
(2). These measurements showed that increasing the molar fraction 
of hydrophobic aldehyde increased the size and thus the cationic 
character of the resulting polymeric nanoparticles (Figure S4b). The 
maximum increase was observed around at molar fraction of χ2 = 
0.3-0.4 and further increase caused an important decrease in both the 
size and the zeta potential (Figure S4B). These results confirmed 
that changes in the aldehyde molar ratios are directly translated into 
the composition of the hydrazone-modified polymer. 
 
Figure 1. GPC (λAbs = 275 nm) analysis of P1 incubated with (1 (¢), 0.75 (p), 
0.5 (¿), 0.25 (£), 0 () equiv and pure () 4-imidazolecarboxaldehyde; 
Conditions: (100 mM acetic acid, pH 2.9, 2 h). Inset: Increase in absorbance of 
the high molecular weight peak (Rt 18 min) with increasing amounts of 4-
imidazolecarboxaldehyde. 
SH
OHN
NH2
O
O
n
P1
OHN
N
O
HO
m
OHN
N
SH RNAi
eGFP 
mRNAHydrazone-activated Polymer
+
polyplex
R
O
H R = Hydrophobic
MGua
60 oC, 2 h, DMSO/H2O (1:1)
χ = 0
N
H
N
H
O
H2N
H2N
H
O
1
χ = 1
χ = 1 χ = 0
 
3 
 
Figure 2. Representation of YMax vs EC50 for the DNA transport experiments in 
EYPC-LUVs⊃HPTS/DPX for hydrazone-activated polymers at χHydrophobic: 
0.15 and χ1: 0.85. 
 
Figure 3. A) Transfection efficiency (grey bars) and cell viability (red circles) in 
HeLa-EGFP, at a constant siRNA (14 nM) and P1(1)85(2)15 (4 µM) 
concentrations and prepared with different molar fractions of 2. B) Dose-
response curves of lead candidate P1(1)85(2)15 (black circles, EC50 = 0.09 
ng/mL) and Lipofectamine RNAiMAX® (grey squares, EC50 = 2.5 ng/mL) and 
cell viability for P1(1)85(2)15 (red circles). 
Lead hydrazone-activated polymers from DLS analysis were 
then evaluated in supramolecular DNA transport experiments using 
large unilamellar vesicles (Egg yolk L-α-phosphatidylcholine) 
loaded with 8-hydroxypyrene-1,3,6-trisulfonic acid trisodium salt 
and p-xylene-bis-pyridinium bromide (EYPC 
LUVs⊃HPTS/DPX).[19,20] This routine assay reports on internal dye 
release as an increase in the HPTS fluorescence (Figure S5). This 
model allows the quick identification of inactive formulations as 
well as compositions that lead to significant membrane damage. In 
these experiments, a heterogeneous mixture of short dsDNAs 
(Herring DNA) was selected to model siRNA. Transport 
experiments in these fluorogenic vesicles revealed isovaleraldehyde 
(2), hexanal (3) and 2-naphthaldehyde (4), and benzaldehyde (5) as 
the leading hits for the aliphatic and the aromatic series respectively 
(Figures 2 and S8, Table S2). Increasing the molar fraction of 
hydrophobic aldehydes over (χHydrophobic > 0.15) afforded 
amphiphilic polymers with membrane disrupting behaviors (Figure 
S6). Control experiments confirmed lack of activity for the parent 
hydrazide P1 either pure or independently combined with 
hydrophilic (1) or hydrophobic aldehydes (Figure S7). 
Following the synthesis and in situ screening of polyhydrazones 
for membrane activity and DNA transport, the aldehyde lead 
candidates from fluorogenic assays, 2, 3, 4 and 5, were taken 
forward for their evaluation in siRNA delivery (GFP knockdown) in 
HeLa-EGFP cells (Figure 3, see SI for details).[31] Again, isolation 
and purification of the synthesized activated polymers was not 
required and transfection experiments were performed by simply 
diluting freshly prepared polyhydrazones (buffer/DMSO, see SI for 
details) in culture media. In these experiments, activated polymers 
with aldehydes 3, 4 and 5 showed no activity for siRNA delivery in 
cells (Figure S11). Aliphatic isovaleraldehyde (2) however showed 
efficient EGFP knockdown with an accurate reproducibility in all 
the transfection replicates measured (Figures S9-S14). 
The biocompatible experimental conditions for hydrazone-
activated polymers preparation allowed the straightforward 
optimization of this polymeric vector. We evaluated P1 with 
different molar ratios of isovaleraldehyde (χ2 = 0-0.4) and different 
polymer concentrations to maximise transfection efficiency and cell 
viability (Figures 3 and S15). Interestingly, the optimum molar ratio 
of the hydrophobic aldehyde (χ2 = 0.15, Figure 3A) correlated well 
with the molar ratio identified in vesicle transport experiments 
(Figures 2, S6 and S8). Maximum transfection efficiency for 
P1(1)85(2)15 (where the subindex indicate the percentage of the 
corresponding aldehyde) could be achieved at a concentration of 4 
µM (Figure S12). Under these conditions, we could confirm the 
formation of supramolecular polyplexes (150 nm) with a positive ζ-
potential of + 7 mV (Figure S17). Additionally, gel electrophoresis 
showed complete complexation of RNA into the polymeric 
polyplexes with as little as 0.12 µM of P1(1)85(2)15 (Figure S18). 
Cell viability was optimal for the parent polymer P1 and for all 
the range of molar fractions and concentrations of the active 
P1(1)85(2)15 (Figure 3A, Figure S15 and S16). However, increasing 
the molar ratio of the hydrophobic aldehyde (χ2 = 0.4) caused a 
slight decrease in cell viability together with an increase in the 
standard deviation of the assay (Figure 3A, red circles). This 
observation could be related with the membrane detergent behavior 
detected for highly hydrophobic polyhydrazones in vesicles 
experiments (Figure 3A and Figure S15, Figure S6). Remarkably, 
the comparison of the dose response curves of transfection 
efficiency revealed that the polymeric vector performed with almost 
equal efficiency using more than ten times less concentration than 
the commercial reagent lipofectime RNAiMAX® (Figure 3B). 
Furthermore, the stability of all the components involved in the 
preparation of this polymeric cytofectin, allowed the storage of the 
stock solutions for months while keeping intact their transfection 
efficiency. 
In conclusion, we have developed a novel strategy for the in 
situ (i.e. in aqueous conditions and without purification) evaluation 
of polymers with biological activity. Poly(hydrazide) functionality 
has been “activated”, under aqueous conditions, to yield 
amphiphilic functional polymers that did not require any further 
purification for their evaluation in relevant biological assays. This 
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protocol allowed the rapid identification of a single component 
supramolecular polymeric formulation for siRNA transfection with 
better performance than the current gold standard for siRNA 
delivery. We believe that the reported methodology is not limited to 
the screening of polynucleotide delivery and that it can be easily 
adapted (through an informed choice of aldehydes) for the high-
throughput screening of polymers with complex chemical 
functionalities and different biological relevance. The control over 
the distribution and sequential arrangement of the aldehyde groups 
onto the polymer scaffold will be a great future challenge that will 
allow the extraction of intriguingly topology/activity relationships. 
Our efforts in these directions will be reported in due course. 
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